HRMY
Harmony Biosciences Holdings, Inc.
1W: -0.9%
1M: -2.1%
3M: -29.0%
YTD: -26.2%
1Y: -19.4%
3Y: -37.2%
5Y: -10.8%
$27.59
+0.49 (+1.81%)
After Hours: $27.54 (-0.05, -0.18%)
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
Smart Money Score
Bullish
75
Insider+$13.6M
Congress—
ETF Holdings—
Key Statistics
Market Cap$1.6B
52W Range25.52-40.87
Volume535,967
Avg Volume858,091
Beta0.91
Dividend—
Analyst Ratings
Company Info
CEOJeffrey Dayno
Employees268
SectorHealthcare
IndustryBiotechnology
IPO Date2020-08-19
Websiteharmonybiosciences.com
630 West Germantown Pike
Plymouth Meeting, PA 19462
US
Plymouth Meeting, PA 19462
US
484 539 9800
About Harmony Biosciences Holdings, Inc.
Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, develops and commercializes therapies for patients with rare neurological disorders in the United States. Its product, WAKIX is a medication for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. The company was formerly known as Harmony Biosciences II, Inc. and changed its name to Harmony Biosciences Holdings, Inc. in February 2020. Harmony Biosciences Holdings, Inc. was incorporated in 2017 and is based in Plymouth Meeting, Pennsylvania.
Latest News
Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) Receives Average Recommendation of “Hold” from Brokerages
Are Options Traders Betting on a Big Move in Harmony Biosciences Stock?
Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) Short Interest Up 47.0% in February
Harmony Biosciences Holdings, Inc. $HRMY Shares Acquired by American Century Companies Inc.
HC Wainwright Issues Pessimistic Forecast for HRMY Earnings
Recent Insider Trades
| Name | Type | Shares | Price | Date |
|---|---|---|---|---|
| Kapadia Sandip | S-Sale | 3,746 | $37.15 | 2026-01-26 |
| Kapadia Sandip | M-Exempt | 4,725 | — | 2026-01-25 |
| Kapadia Sandip | F-InKind | 2,553 | $36.82 | 2026-01-25 |
| Kapadia Sandip | M-Exempt | 4,725 | — | 2026-01-25 |
| Serafin Andrew | M-Exempt | 2,600 | — | 2026-01-25 |